Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia

DEMİRKAN F., SEVİNDİK Ö. G., KARAMAN A., ALACACIOĞLU İ., Solmaz S. M., ÖZSAN G. H.

51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • Doi Number: 10.1200/jco.2015.33.15_suppl.e18024
  • City: Illinois
  • Country: United States Of America
  • Dokuz Eylül University Affiliated: Yes